NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 16 04:00PM ET
0.1820
Dollar change
+0.0026
Percentage change
1.45
%
Index- P/E- EPS (ttm)-1.05 Insider Own12.88% Shs Outstand86.37M Perf Week-7.19%
Market Cap15.72M Forward P/E- EPS next Y-0.37 Insider Trans9.94% Shs Float75.24M Perf Month-21.04%
Income-52.30M PEG- EPS next Q-0.12 Inst Own22.27% Short Float3.58% Perf Quarter-53.21%
Sales3.02M P/S5.21 EPS this Y59.23% Inst Trans-20.03% Short Ratio1.43 Perf Half Y-63.18%
Book/sh0.24 P/B0.77 EPS next Y49.60% ROA-121.55% Short Interest2.69M Perf Year-84.04%
Cash/sh0.13 P/C1.41 EPS next 5Y45.66% ROE-271.97% 52W Range0.16 - 1.49 Perf YTD-49.23%
Dividend Est.- P/FCF- EPS past 5Y-18.68% ROI-187.31% 52W High-87.74% Beta0.23
Dividend TTM- Quick Ratio3.12 Sales past 5Y-34.30% Gross Margin-70.96% 52W Low12.21% ATR (14)0.02
Dividend Ex-Date- Current Ratio3.56 EPS Y/Y TTM50.14% Oper. Margin-1653.95% RSI (14)36.59 Volatility10.50% 9.41%
Employees107 Debt/Eq0.61 Sales Y/Y TTM338.75% Profit Margin-1730.00% Recom1.40 Target Price2.25
Option/ShortYes / Yes LT Debt/Eq0.58 EPS Q/Q70.38% Payout- Rel Volume0.89 Prev Close0.18
Sales Surprise14.54% EPS Surprise5.90% Sales Q/Q174.17% EarningsFeb 10 AMC Avg Volume1.88M Price0.18
SMA20-9.31% SMA50-22.33% SMA200-51.20% Trades Volume1,679,098 Change1.45%
Date Action Analyst Rating Change Price Target Change
Jun-25-24Downgrade BTIG Research Buy → Neutral
Jul-28-23Initiated Piper Sandler Overweight $10
Jun-15-23Initiated BTIG Research Buy $15
Apr-28-21Initiated Truist Buy $12
Oct-22-19Initiated Oppenheimer Outperform $9
Apr-24-25 04:05PM
Apr-21-25 04:05PM
Apr-15-25 04:05PM
Apr-09-25 04:05PM
Apr-01-25 08:00AM
08:00AM Loading…
Mar-31-25 08:00AM
Mar-24-25 04:05PM
Mar-23-25 08:38AM
Mar-11-25 07:30AM
Mar-06-25 04:05PM
Feb-10-25 04:05PM
Feb-07-25 07:10AM
Feb-05-25 09:29AM
Jan-27-25 04:05PM
Jan-24-25 09:15AM
08:00AM Loading…
Jan-06-25 08:00AM
Dec-03-24 04:05PM
Dec-02-24 07:30AM
Nov-26-24 07:30AM
Nov-14-24 04:05PM
Nov-11-24 04:05PM
07:00AM
Nov-08-24 07:06AM
Oct-29-24 04:22PM
Oct-07-24 07:00AM
Oct-02-24 07:30AM
Sep-28-24 07:40AM
07:35AM
Sep-27-24 07:34AM
07:32AM
07:30AM Loading…
07:30AM
Sep-23-24 08:00AM
Aug-06-24 04:05PM
Jul-31-24 04:15PM
Jul-23-24 04:05PM
Jul-16-24 04:05PM
Jul-10-24 09:55AM
Jun-26-24 08:01AM
Jun-25-24 10:31AM
08:28AM
07:37AM
Jun-24-24 08:53PM
05:25PM
04:15PM
Jun-13-24 04:05PM
Jun-03-24 07:00AM
May-23-24 04:09PM
May-01-24 07:00AM
Mar-21-24 12:00PM
Mar-20-24 09:00AM
Feb-13-24 08:51AM
Feb-12-24 04:05PM
Jan-18-24 08:00AM
Dec-27-23 07:30AM
Dec-21-23 01:40AM
Nov-15-23 04:05PM
Nov-14-23 10:00AM
Nov-13-23 04:05PM
Nov-03-23 12:00PM
Oct-19-23 04:05PM
Oct-17-23 04:05PM
07:30AM
Oct-16-23 07:30AM
07:00AM
Oct-04-23 07:30AM
Oct-02-23 04:05PM
Sep-27-23 09:00AM
Sep-18-23 04:05PM
Sep-07-23 07:30AM
Sep-06-23 07:00AM
Aug-10-23 04:05PM
Aug-08-23 09:55AM
Aug-07-23 04:05PM
Aug-01-23 04:05PM
Jul-28-23 10:13AM
Jul-24-23 04:05PM
Jun-22-23 04:05PM
Jun-15-23 04:10PM
04:05PM
Jun-09-23 06:34AM
Jun-08-23 06:43AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
Jun-05-23 06:44AM
Jun-02-23 06:56AM
Jun-01-23 06:29AM
May-31-23 06:40AM
May-30-23 06:50AM
May-26-23 06:59AM
May-25-23 06:38AM
May-24-23 06:43AM
May-23-23 06:33AM
May-22-23 07:49AM
May-19-23 07:03AM
May-18-23 06:39AM
May-17-23 06:35AM
May-16-23 04:05PM
Apr-19-23 09:00AM
Mar-31-23 06:36AM
Mar-23-23 04:05PM
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carey RobertDirectorMar 14 '25Buy0.251,000,000250,0504,076,864Mar 17 08:15 AM
Gaul Michael A.Chief Operating OfficerFeb 19 '25Buy0.386,0002,29494,150Feb 21 05:00 PM
Carey RobertDirectorSep 26 '24Buy0.501,476,626744,6621,476,626Oct 01 09:58 PM
Lisi Steven A.CEO and Chairman of the BoardSep 26 '24Buy0.501,476,626744,6623,249,411Oct 01 09:27 PM
Avniel AmirOfficerAug 22 '24Proposed Sale0.46180,41583,442Aug 22 10:13 AM
Lisi Steven A.CEO and Chairman of the BoardAug 15 '24Buy0.3750,00018,3401,772,785Aug 19 06:06 AM
Lucera ErickDirectorAug 14 '24Buy0.4039,26615,56543,608Aug 15 05:09 PM
Carey RobertDirectorAug 14 '24Buy0.40100,00039,6803,076,864Aug 15 05:09 PM
Lisi Steven A.CEO and Chairman of the BoardAug 14 '24Buy0.39100,00038,6401,722,785Aug 15 05:09 PM